#pressrelease
10 min read

Fresh Inset S.A. Files Prospectus with KNF: Rapid Revenue Growth Ahead of Planned Debut in Q1 2027

Polish technology, global reach, and revenue that, after just three quarters of 2026, has already exceeded the full-year result for 2025. Fresh Inset S.A., a Polish deep-tech company whose patented solutions for extending the freshness of fruits, vegetables, and flowers reach five continents, is preparing to debut on the Main Market of the Warsaw Stock Exchange (GPW). The company has filed its prospectus with the Polish Financial Supervision Authority (KNF), and its stock market debut is planned for Q1 2027. The backdrop is rapid business growth: Group revenue for the first nine months of the year reached PLN 8.2 million, up approximately 78% year over year. The debut will take place without a new share issue or a public offering. 

Prospectus Filed with KNF: Next Steps 

The prospectus was prepared in connection with the application for the admission and introduction of all shares of Fresh Inset S.A. to trading on the regulated market (main market) of the GPW. The company is not conducting a public offering and is not issuing new shares, so it will not raise capital as part of the debut. Once the KNF approves the prospectus, the company will apply to the GPW for the admission and introduction of its shares to trading. The debut is planned for Q1 2027 and is subject to the approval of the prospectus and to market conditions. The prospectus contains data for the first three quarters of 2026, a breakthrough year for the company: its first year of industrial-scale production and global distribution of its technology. 

“We see going public as a strategic decision, not an opportunistic one. We are past the proof-of-concept stage and in the middle of full-scale commercialization, with real revenue and customers on several continents. Public company status gives us flexible access to capital when a specific opportunity arises, and it allows us to bring several strategic partners into our shareholder base at the same time. We were founded in Poland, we sell on five continents, and we will be listed on the Polish stock exchange.” 

Dr. Andrzej Wolan, Co-founder and CEO, Fresh Inset S.A. 

2026: Revenue Growing Faster Than Costs 

2025 was the first full year of commercialization of Fresh Inset’s technology, with Group revenue rising from approximately PLN 0.2 million to approximately PLN 6.5 million. In the first three quarters of 2026, revenue reached PLN 8.2 million, compared with PLN 4.6 million a year earlier (up approximately 78%), and exceeded the full-year 2025 result by approximately 26%. In the third quarter alone, revenue reached PLN 6.2 million, compared with PLN 3.3 million a year earlier. North America is the largest market: the United States and Canada account for approximately 62% of revenue, Europe for approximately 26%, and Latin America for approximately 12%. 

“What matters most is that we are growing faster than our costs. Gross margin rose to about 72%, the margin after selling and distribution costs went from negative a year earlier to a positive PLN 2.1 million, and we kept overhead close to the level of the same period in 2025. In the third quarter alone, EBITDA was already close to zero, and the Group’s operating loss was limited to about PLN 0.3 million. This is not the result of a single contract: about 72% of sales came from customers who were already buying our products in 2025. The technology speaks for itself, and we are only beginning to scale it.” 

Krzysztof Czaplicki, Co-founder and CSO, Fresh Inset S.A. 

The 20-Year Deadlock Fresh Inset Has Broken 

Almost half of the fresh fruits and vegetables that leave the field are never consumed (FAO), with losses reaching approximately USD 88 billion a year. The culprit is ethylene, a natural plant hormone responsible for ripening and spoilage. For more than 20 years, the industry has known a substance that blocks it: 1-MCP, the “penicillin of agriculture,” approved in more than 70 countries, including the US and the EU. The market challenge, therefore, was not the substance itself but the lack of effective ways to apply it: 1-MCP was released rapidly, so it required an airtight chamber. In practice, for two decades 1-MCP was used mainly on apples and pears in dedicated cold storage facilities. Fresh Inset solved this problem with two proprietary platforms: 

  • Vidre+®: the company was the first to develop and patent the delayed, gradual release of 1-MCP from a sticker, label, print, or film directly inside the package. With Vidre+, ordinary packaging becomes active freshness protection at the producer, in transit, and on the shelf, without significant changes to the customer’s infrastructure. The technology works across more than 40 crops: blueberries maintain good quality approximately 20 days longer; cherries retain more mass, which cuts commercial losses from weight loss by 25% (study published in Scientific Reports, Springer Nature); and roses last five days longer in the vase. 
  • MaTri®: 1-MCP for self-application in a storage chamber, container, or trailer, with no service provider or laboratory required. The customer calculates the dose in the proprietary DoseRightTM online calculator, applies the tablets or powder on their own, and the next day sees confirmation of effectiveness on the color-changing MaTri SURETM indicator. All it takes is a tightly sealed space, which removes the key limitations of traditional 1-MCP and expands the market many times over. 
  • The offering is rounded out by a classic first-generation 1-MCP powder: an entry point for fruit growers who know the substance from storage facilities and a pathway for moving them to Fresh Inset’s proprietary solutions. 

 

“The technology had existed for 20 years and was waiting for the right delivery method. We invented it in Toruń and patented it worldwide. MaTri freed 1-MCP from the need for specialized service providers, and Vidre+ freed it from the chamber altogether. The cold store is no longer the only place where protection happens. Every package becomes one. For a proven, safe substance, this opens up practically the entire market for fresh fruits, vegetables, and flowers. For our customers, this is not an additional cost, because we enable them to earn more from the same harvest.” 

Dr. Andrzej Wolan, CEO, Fresh Inset S.A. 

Deep Tech That Is Already Selling 

Fresh Inset combines an active ingredient, proprietary patents, product registrations, and top-tier partners with revenue on five continents. 

  • Barriers to entry on par with pharma. A portfolio of 27 granted patents and numerous pending patent applications protects the compositions and the 1-MCP release mechanism. Each product requires a separate registration in each country, a process that takes anywhere from more than a year to three or four years. Fresh Inset holds registrations or the right to sell in more than ten markets, including the US (FDA and EPA), Canada, the EU, and Latin America, with further proceedings underway in South Africa, Australia, and New Zealand, among others. 
  • Partners whose validation cannot be bought. NYSE-listed Avery Dennison (approximately USD 8.9 billion in revenue) has signed a contract manufacturing agreement for Vidre+®. In the US, the company’s distributor is one of the world’s largest agrochemical groups. In addition, the global leader in cut-flower care products will take over exclusive distribution of Fresh Inset products in the floral segment on five continents from 2027 and has also become a shareholder in the company. 
  • Two large markets. The technology targets the post-harvest market (approximately USD 12 billion) and the functional packaging market (approximately USD 33 to 35 billion), and every additional link in the chain, from cold storage through cartons to packaging on the shelf, multiplies the volume of protected produce. 

Shareholders: Funds, an Industry Investor, Individual Investors, and Rubicon Partners’ Listed Vehicle 

Since its founding, Fresh Inset has raised more than PLN 67 million from investors in five private-market rounds, as well as approximately PLN 12 million in grants. Each stage of development was validated by an investor suited to it: in the seed round, Infini, a fund co-financed by Poland’s National Centre for Research and Development (NCBR); in the Series A round, Montis Capital, a fund backed by the Polish Development Fund (PFR); in the late-stage Series B round, Radix Ventures, a fund backed by the European Investment Fund (EIF); and in the oversubscribed pre-IPO round closed in Q2 2026, a global industry leader that is now also the company’s distribution partner. Fresh Inset also completed one of the largest rounds in Poland aimed exclusively at individual investors, raising almost PLN 20 million from business angels. The co-founders, Synthex Technologies, and Rubicon Partners have been shareholders since the first round in 2017. 

In recent days, R Ventures II, the investment vehicle of the Rubicon Partners Group listed on NewConnect (the GPW’s alternative trading system), also disclosed its shareholding. It currently still trades as Voolt S.A. (ticker: VLT) and is in the process of changing its name to R Ventures II S.A. R Ventures II has invested approximately PLN 6.8 million in Fresh Inset, its largest investment to date and its first in a company at the final stage before going public. The debut of Fresh Inset S.A. does not involve a public offering or the issue of new shares. Once the KNF approves the prospectus and the shares are admitted and introduced to trading on the GPW, the company’s existing shares will be traded on the exchange. 

This communication constitutes an advertisement within the meaning of Article 22 of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 (the “Prospectus Regulation”) and is for promotional purposes only. It does not constitute a public offering, an offer to acquire, or an invitation to submit offers to acquire securities, nor does it constitute an investment recommendation. Fresh Inset S.A. is not conducting a public offering of shares. The prospectus of Fresh Inset S.A., prepared in connection with the application for the admission and introduction of the Company’s shares to trading on the regulated market operated by the Warsaw Stock Exchange (Giełda Papierów Wartościowych w Warszawie S.A.), has not yet been approved by the Polish Financial Supervision Authority (Komisja Nadzoru Finansowego, “KNF”). Once approved, the prospectus will be the sole legally binding document containing information about the Company and its shares and will be published on the Company’s website (freshinset.com). The approval of the prospectus by the KNF should not be understood as an endorsement of the securities to be admitted to trading. Before making an investment decision, potential investors should read the prospectus, in particular the risk factors, in order to fully understand the potential risks and rewards associated with the decision to invest in the Company’s shares.


Media contact: [email protected] | [email protected] | +48 796 938 302 

Learn more: freshinset.com | ma-tri.com 

About Fresh Inset 

Fresh Inset S.A. is a Polish deep-tech company that has developed and is commercializing proprietary, patented technologies that extend the freshness of harvested fruits and vegetables and cut flowers across the entire supply chain, from cold storage through packhouses and transport to the store shelf. In doing so, it addresses one of the largest and least visible problems in the global economy: almost half of the fresh produce that leaves the field is never consumed. 

The technology is based on 1-MCP, an active ingredient with a proven safety profile that has been used industrially for more than 20 years, until now mainly for apples and pears stored in airtight chambers. Fresh Inset was the first to develop and patent a form of delayed, gradual release of 1-MCP from a sticker, label, print, or film directly inside the package (the Vidre+® platform), as well as solutions for the self-application of 1-MCP in any tightly sealed space (the MaTri® platform). As a result, ordinary packaging becomes active freshness protection at every stage of the supply chain without significant changes to the customer’s infrastructure, and a proven substance gains access to the entire market for fresh agricultural produce. 

The company operates in a highly regulated market in which every jurisdiction requires a separate product registration. Together with 27 granted patents and numerous pending patent applications, this creates barriers to entry comparable to those in the pharmaceutical market. Fresh Inset holds registrations or the right to sell in more than ten markets, including the US (FDA and EPA), Canada, the EU, and Latin America; it operates commercially on five continents and works with global leaders in their industries across manufacturing, distribution, and its shareholder base. The company was founded in 2017 in Toruń as a spin-off with the participation of Synthex Technologies and Rubicon Partners. Since then, it has raised more than PLN 67 million in five funding rounds and approximately PLN 12 million in grants. In November 2026, it filed a prospectus with the KNF in connection with its debut on the GPW Main Market, planned for Q1 2027. 

Related articles